MedPath

Pantoprazole Sodium

These highlights do not include all the information needed to use PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS. PANTOPRAZOLE sodium delayed-release tablets, for oral use Initial U.S. Approval: 2000

Approved
Approval ID

7d77134c-2082-39e8-e053-2991aa0a4a3b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 20, 2018

Manufacturers
FDA

medsource pharmaceuticals

DUNS: 833685915

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Pantoprazole Sodium

PRODUCT DETAILS

NDC Product Code45865-785
Application NumberANDA078281
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateDecember 20, 2018
Generic NamePantoprazole Sodium

INGREDIENTS (10)

FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
GLYCERYL DIBEHENATEInactive
Code: R8WTH25YS2
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)Inactive
Code: 74G4R6TH13
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
TRIETHYL CITRATEInactive
Code: 8Z96QXD6UM
Classification: IACT
PANTOPRAZOLE SODIUMActive
Quantity: 40 mg in 1 1
Code: 6871619Q5X
Classification: ACTIM
© Copyright 2025. All Rights Reserved by MedPath
Pantoprazole Sodium - FDA Approval | MedPath